217 filings
Page 2 of 11
8-K
ilhs1dpgnwu1
21 Jan 09
Other Events
12:00am
8-K
mm3ty9
22 Dec 08
Other Events
12:00am
8-K
rgcg0g mj6
10 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
fbrdx8gicfvm0vna
3 Dec 08
Other Events
12:00am
8-K
qgt9m8jm
12 Nov 08
AtheroGenics Reports Third Quarter 2008 Financial Results
12:00am
NT 10-Q
ypsl7 bbh4o
12 Nov 08
Notice of late quarterly filing
12:00am
8-K
0sdibe39
10 Oct 08
AtheroGenics Receives Delisting Notice from NASDAQ Global Market Due to Chapter 11 Filing
12:00am
RW
o8pg9kuv
10 Oct 08
Registration withdrawal request
12:00am
8-K
9us9snfo
7 Oct 08
Bankruptcy or Receivership
12:00am
8-K
n00p1o
23 Sep 08
Cost Associated with Exit or Disposal Activities
12:00am
8-K
9az49
18 Sep 08
Departure of Directors or Principal Officers
12:00am
8-K
l9f00
16 Sep 08
Other Events
12:00am
8-K
ihkwop f4plok20ytr
11 Sep 08
Departure of Directors or Principal Officers
12:00am
8-K
olj26kodgndm b3
2 Sep 08
Triggering Events That Accelerate or Increase a Direct Financial Obligation under an Off-Balance Sheet Arrangement
12:00am
CT ORDER
ja5np10 onqbwa
25 Aug 08
Confidential treatment order
12:00am
8-K
0i4hc 8h68
5 Aug 08
AtheroGenics Reports Second Quarter 2008 Financial Results
12:00am
8-K
kzemy1
31 Jul 08
AtheroGenics Reports Positive Results from ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
12:00am
8-K
pyatd2ldzy0zo ce8tc
30 Jun 08
AtheroGenics Receives Notice of Non-Compliance with Listing Requirement for the NASDAQ Global Market
12:00am